ABUS Arbutus Biopharma Corporation - Common Stock

NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗

$4,29

Harga · Mei 20, 2026

Fundamental per Mei 13, 2026

ABUS Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

Harga

$4.29

Kapitalisasi Pasar

$926M

P/E (TTM)

-28.3

EPS (TTM)

$-0.17

Pendapatan (TTM)

$14M

Imbal Hasil Dividen

—

ROE

-42.0%

D/E Utang/Ekuitas

—

Rentang 52M

$3 – $5

ABUS Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

Pendapatan & Laba Bersih $14M

2016-12-31 → 2025-12-31

EPS $-0.17

2016-12-31 → 2025-12-31

Arus Kas Bebas $-40M

2016-12-31 → 2025-12-31

Margin -237.9%

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik

Tren 5 Tahun

ABUS

Median Rekan

P/E (TTM)

-28.3

7.0

P/S (TTM)

65.8

22.0

P/B

12.1

6.1

Price / FCF (Harga / FCF)

-23.4

—

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik

Tren 5 Tahun

ABUS

Median Rekan

Operating Margin (Margin Operasi)

-271.0%

—

Net Profit Margin (Margin Laba Bersih)

-237.9%

-202.2%

ROA

-29.6%

-32.5%

ROE

-42.0%

-42.4%

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik

Tren 5 Tahun

ABUS

Median Rekan

Current Ratio (Rasio Lancar)

15.7

8.7

Quick Ratio (Rasio Cepat)

15.5

—

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik

Tren 5 Tahun

ABUS

Median Rekan

Revenue YoY (Pendapatan YoY)

128.2%

—

Revenue CAGR 3Y (CAGR Pendapatan 3T)

-28.8%

—

Revenue CAGR 5Y (CAGR Pendapatan 5T)

15.3%

—

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik

Tren 5 Tahun

ABUS

Median Rekan

EPS (Diluted)

$-0.17

—

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik

Tren 5 Tahun

ABUS

Median Rekan

ABUS Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

BELI 9 analis

Beli Kuat 3 33,3%
Beli 5 55,6%
Tahan 1 11,1%
Jual 0 0,0%
Jual Kuat 0 0,0%

Target Harga 12 Bulan

3 analis · 2026-05-18

Median $5.04

Rata-rata $5.17

← Di bawah semua target $4.29

Rendah $4.97

Tinggi $5.50

Target median $5.04 +17,5%

Target rata-rata $5.17 +20,5%

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

Kejutan Rata-rata

0.01%

Periode	EPS Aktual	EPS Estimasi	Kejutan
31 Maret 2026	$-0.05	$-0.03	-0.02%
31 Des. 2025	$-0.02	$-0.04	0.02%
30 Sep. 2025	$-0.04	$-0.03	-0.01%
30 Juni 2025	$0.01	$-0.05	0.06%
31 Maret 2025	$-0.13	$-0.11	-0.02%
31 Des. 2024	$-0.07	$-0.08	0.01%

Perbandingan Sejawat Metrik utama vs rekan sektor

Ticker	Kapitalisasi Pasar	P/E	Pendapatan YoY	Margin Bersih	ROE	Margin Kotor
ABUS	$926M	-28.3	128.2%	-237.9%	-42.0%	—
XENE	$3.59B	-10.3	—	-4612.1%	-56.9%	—
AUPH	$2.11B	7.7	20.4%	101.5%	62.7%	—
ZYME	$1.97B	-24.4	38.9%	-76.6%	-26.9%	—
ACOG	$141M	-5.5	—	-202.2%	-43.8%	—

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

Laporan Laba Rugi 16

Data Laporan Laba Rugi Tahunan untuk ABUS
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2017	2016	2015
Revenue	$14M	$6M	$18M	$39M	$11M	$7M	$6M	$6M	$11M	·	$1M	$23M
R&D Expense	$25M	$54M	$74M	$84M	$66M	$49M	$58M	$58M	$63M	·	$61M	$52M
SG&A Expense	$16M	$22M	$22M	$18M	$17M	$15M	$18M	$16M	$16M	·	$39M	$26M
Operating Expenses	$52M	$82M	$96M	$104M	$85M	$65M	$150M	$96M	$122M	·	$493M	$127M
Operating Income	$-38M	$-76M	$-78M	$-65M	$-74M	$-58M	$-144M	$-90M	$-111M	·	$-492M	$-104M
Interest Expense	·	·	$459.0K	$2M	$3M	$4M	$2M	$226.0K	$261.0K	·	$0	$0
Interest Income	$4M	$7M	$6M	$2M	$127.0K	$741.0K	$2M	$3M	$2M	·	$1M	$674.0K
Other Non-op	$5M	$6M	$5M	$444.0K	$-3M	$-6M	$-22M	$28M	$2M	·	$2M	$25M
Pretax Income	·	·	·	·	·	$-64M	$-166M	$-61M	$-109M	·	$-489M	$-79M
Income Tax	$0	$0	$0	$4M	$0	$0	$-13M	$-4M	$-24M	·	$-105M	$-16M
Net Income	$-34M	$-70M	$-73M	$-69M	$-76M	$-64M	$-154M	$-57M	$-84M	·	$-384M	$-63M
EPS (Basic)	$-0.17	$-0.38	$-0.44	$-0.46	$-0.83	$-1.00	·	$-1.21	$-1.56	·	$-7.24	$-1.38
EPS (Diluted)	$-0.17	$-0.38	$-0.44	$-0.46	$-0.83	$-1.00	·	$-1.21	$-1.56	·	$-7.24	$-1.38
Shares (Basic)	191,599,600	185,608,874	165,960,379	150,939,337	106,242,452	75,835,378	·	55,304,083	54,723,272	·	53,074,401	45,462,324
Shares (Diluted)	191,599,600	185,608,874	165,960,379	150,939,337	106,242,452	75,835,378	·	55,304,083	54,723,272	·	53,074,401	45,462,324
EBITDA	$-38M	$-76M	$-78M	$-65M	$-74M	$-58M	·	$-90M	$-111M	·	$-492M	·

Neraca 25

Data Neraca Tahunan untuk ABUS
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2017	2016	2015
Cash & Equivalents	$18M	$36M	$26M	$31M	$109M	$52M	$32M	$37M	$54M	$30M	$23M	$167M
Short-term Investments	$73M	$86M	$100M	$116M	$46M	$71M	$59M	$88M	$72M	·	$107M	$15M
Receivables	$1M	$2M	$2M	$1M	$899.0K	$1M	$1M	$1M	$402.0K	·	$273.0K	$1M
Prepaid Expense	$2M	$2M	$4M	$3M	$4M	$3M	$2M	$3M	$2M	·	$1M	$1M
Current Assets	$94M	$127M	$132M	$151M	$161M	$128M	$94M	$129M	$129M	·	$133M	$184M
PP&E (Net)	$32.0K	$3M	$5M	$5M	$6M	$7M	$9M	$10M	$12M	·	$7M	$3M
PP&E (Gross)	$245.0K	$16M	$17M	$16M	$15M	$15M	$14M	$17M	$25M	·	$18M	$13M
Accum. Depreciation	$213.0K	$13M	$12M	$11M	$9M	$8M	$6M	$7M	$13M	·	$11M	$10M
Goodwill	·	·	·	·	·	·	$0	$22M	$24M	·	$24M	$163M
Intangibles	·	·	·	·	·	·	$0	$44M	$59M	·	$99M	$353M
Other Non-current Assets	$130.0K	$34.0K	$0	$103.0K	$61.0K	$44.0K	$293.0K	$0	·	·	·	·
Total Assets	$95M	$132M	$144M	$195M	$204M	$137M	$106M	$228M	$237M	·	$276M	$712M
Accounts Payable	$5M	$8M	$10M	$16M	$11M	$9M	$7M	$9M	$11M	·	$10M	$9M
Current Liabilities	$6M	$16M	$22M	$33M	$11M	$10M	$8M	$11M	$15M	·	$11M	$11M
Capital Leases	$199.0K	$806.0K	$1M	$2M	$2M	$3M	$3M	$0	·	·	·	·
Deferred Tax	·	·	·	·	·	·	$0	$13M	$17M	·	$41M	$146M
Total Liabilities	$18M	$34M	$38M	$59M	$35M	$35M	$33M	$28M	$55M	·	$73M	$165M
Long-term Debt	$0	$0	$0	$0	$0	·	·	·	·	·	·	·
Common Stock	$1.42B	$1.41B	$1.35B	$1.32B	$1.29B	$986M	$899M	$879M	$876M	·	$867M	$834M
Paid-in Capital	$83M	$82M	$81M	$72M	$65M	$61M	$55M	$48M	$43M	·	$37M	$30M
Retained Earnings	$-1.38B	$-1.35B	$-1.28B	$-1.20B	$-1.13B	$-1.05B	$-970M	$-805M	$-738M	·	$-653M	$-267M
AOCI	$-48M	$-48M	$-48M	$-50M	$-48M	$-48M	$-48M	$-48M	$-48M	·	$-48M	$-50M
Stockholders' Equity	$77M	$97M	$106M	$137M	$169M	$102M	$73M	$200M	$182M	·	$203M	$548M
Liabilities + Equity	$95M	$132M	$144M	$195M	$204M	$137M	$106M	$228M	$237M	·	$276M	$712M
Shares Outstanding	192,531,225	189,963,492	169,867,414	157,455,363	144,987,736	89,678,722	64,780,314	55,518,800	55,060,650	·	54,841,494	54,570,691

Arus Kas 14

Data Arus Kas Tahunan untuk ABUS
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2017	2016	2015
Stock-based Comp	$7M	$9M	$9M	$7M	$6M	$6M	$7M	$6M	$15M	·	·	·
Deferred Tax	·	·	·	·	·	$0	$-13M	$-4M	$-24M	·	$-105M	$-16M
Restructuring	$13M	$4M	$0	·	$0	$64.0K	$156.0K	$5M	$0	·	·	·
Operating Cash Flow	$-40M	$-65M	$-86M	$-35M	$-68M	$-51M	$-71M	$-68M	$-49M	·	$-58M	$-56M
CapEx	$0	$182.0K	$1M	$512.0K	$809.0K	$229.0K	$589.0K	$1M	$7M	·	$4M	$2M
Investing Cash Flow	$16M	$23M	$51M	$-75M	$-13M	$-15M	$28M	$-4M	$28M	·	$-99M	$8M
Debt Issued	·	·	·	·	·	·	·	·	$0	·	$12M	$0
Net Debt Issued	·	·	·	·	·	·	·	·	$0	·	$12M	·
Stock Issued	·	·	·	·	$135M	$86M	$19M	$0	$0	·	$0	$142M
Net Stock Activity	·	·	·	·	$135M	$86M	·	·	$0	·	$0	·
Financing Cash Flow	$6M	$52M	$31M	$32M	$137M	$87M	$37M	$56M	$49M	·	$13M	$144M
Net Change in Cash	$-18M	$10M	$-4M	$-79M	$57M	$20M	$-5M	$-17M	$31M	·	$-143M	$95M
Free Cash Flow	$-40M	$-65M	$-87M	$-36M	$-68M	$-52M	·	$-69M	$-56M	·	$-62M	·
Levered FCF	·	·	·	·	·	$-56M	·	$-69M	$-56M	·	·	·

Profitabilitas 7

Data Profitabilitas Tahunan untuk ABUS
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2017	2016	2015
Operating Margin	-271.0%	-1236.7%	-430.5%	-167.8%	-669.1%	-836.1%	·	-1510.2%	-1036.7%	·	-32973.8%	·
Net Margin	-237.9%	-1133.0%	-401.6%	-178.0%	-693.9%	-922.0%	·	-959.8%	-788.9%	·	-25765.5%	·
Pretax Margin	·	·	·	·	·	-922.0%	·	-1031.8%	-1016.2%	·	-32807.9%	·
EBITDA Margin	-271.0%	-1236.7%	-430.5%	-167.8%	-669.1%	-836.1%	·	-1510.2%	-1036.7%	·	-32973.8%	·
ROA	-29.6%	-50.6%	-42.9%	-34.7%	-44.6%	-52.5%	·	-24.5%	-32.9%	·	-77.8%	·
ROE	-42.0%	-68.5%	-64.6%	-49.2%	-50.9%	-64.0%	·	-27.5%	-43.8%	·	-102.4%	·
ROIC	·	·	·	·	·	-56.7%	·	-41.7%	-47.2%	·	-190.2%	·

Likuiditas & Solvabilitas 3

Data Likuiditas & Solvabilitas Tahunan untuk ABUS
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2017	2016	2015
Current Ratio	15.7	8.2	5.9	4.6	14.3	13.4	·	11.5	8.8	·	12.5	·
Quick Ratio	15.5	8.0	5.7	4.5	13.9	13.1	·	11.2	8.7	·	12.4	·
Interest Coverage	·	·	-170.2	-37.9	-25.7	-14.4	·	-397.3	-425.0	·	·	·

Efisiensi 2

Data Efisiensi Tahunan untuk ABUS
Metrik	Tren	2025	2024	2023	2022	2021	2020	2019	2018	2017	2017	2016	2015
Asset Turnover		0.1	0.0	0.1	0.2	0.1	0.1	·	0.0	0.0	·	0.0	·
Receivables Turnover		7.3	2.9	11.6	34.7	9.9	5.5	·	6.5	31.7	·	2.3	·

Per Saham 5

Data Per Saham Tahunan untuk ABUS
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2017	2016	2015
Book Value / Share	$0.40	$0.51	$0.62	$0.87	$1.17	$1.14	·	$3.61	$3.31	·	$3.70	·
Revenue / Share	$0.07	$0.03	$0.11	$0.26	$0.10	·	·	$0.11	$0.20	·	$0.03	·
Cash Flow / Share	$-0.21	$-0.35	$-0.52	$-0.23	$-0.64	·	·	$-1.23	$-0.89	·	$-1.09	·
Cash / Share	$0.09	$0.19	$0.15	$0.20	$0.75	$0.58	·	$0.67	$0.99	·	$0.43	·
EPS (TTM)	$-0.17	$-0.38	$-0.44	$-0.46	$-0.83	$-1.00	$-1.32	$-1.21	$-1.56	·	$-7.24	$-1.38

Tingkat Pertumbuhan 3

Data Tingkat Pertumbuhan Tahunan untuk ABUS
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2017	2016	2015
Revenue YoY	128.2%	-66.0%	-53.5%	255.1%	58.9%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-28.8%	-17.5%	37.9%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	15.3%	·	·	·	·	·	·	·	·	·	·	·

Valuasi (TTM) 10

Data Valuasi (TTM) Tahunan untuk ABUS
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2017	2016	2015
Revenue TTM	$14M	$6M	$18M	$39M	$11M	$7M	$6M	$6M	$11M	$1M	$1M	$23M
Net Income TTM	$-34M	$-70M	$-73M	$-69M	$-76M	$-64M	$-154M	$-57M	$-84M	$-387M	$-384M	$-63M
Market Cap	$926M	$621M	$425M	$367M	$564M	$318M	·	$213M	$278M	·	$134M	·
P/E	-28.3	-8.6	-5.7	-5.1	-4.7	-3.5	-2.1	-3.2	-3.2	·	-0.3	-3.2
P/S	65.8	100.7	23.4	9.4	51.3	46.0	·	35.8	26.0	·	90.1	·
P/B	12.1	6.4	4.0	2.7	3.3	3.1	·	1.1	1.5	·	0.7	·
P / Tangible Book	12.1	6.4	4.0	2.7	3.3	3.1	·	·	·	·	·	·
P / Cash Flow	-23.4	-9.6	-4.9	-10.4	-8.4	-6.2	·	-3.1	-5.7	·	-2.3	·
P / FCF	-23.4	-9.6	-4.9	-10.2	-8.3	-6.2	·	-3.1	-5.0	·	-2.2	·
Earnings Yield	-3.5%	-11.6%	-17.6%	-19.7%	-21.3%	-28.2%	-47.5%	-31.6%	-30.9%	·	-295.5%	-31.0%

Laporan Laba Rugi 16

Data Triwulanan Laporan Laba Rugi untuk ABUS
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$179M	$1M	$529.0K	$11M	$2M	$2M	$1M	$2M	$2M	$2M	$5M	$5M	$7M	$6M	$6M	$14M
R&D Expense	$4M	$5M	$6M	$5M	$9M	$9M	$14M	$16M	$15M	$18M	$20M	$18M	$18M	$23M	$20M	$23M
SG&A Expense	$6M	$4M	$3M	$3M	$6M	$5M	$5M	$8M	$5M	$5M	$6M	$6M	$6M	$4M	$3M	$5M
Operating Expenses	$10M	$6M	$9M	$9M	$27M	$16M	$23M	$23M	$21M	$23M	$26M	$23M	$24M	$29M	$24M	$28M
Operating Income	$169M	$-5M	$-9M	$1M	$-26M	$-14M	$-21M	$-22M	$-19M	$-21M	$-22M	$-18M	$-17M	$-23M	$-18M	$-14M
Interest Expense	·	·	·	·	·	·	·	$34.0K	$44.0K	·	$46.0K	$171.0K	$198.0K	$309.0K	$429.0K	$482.0K
Interest Income	$815.0K	$877.0K	$952.0K	$1M	$1M	$1M	$2M	$2M	$2M	$1M	$1M	$1M	$1M	$943.0K	$694.0K	$396.0K
Other Non-op	$787.0K	$2M	$917.0K	$1M	$1M	$1M	$2M	$2M	$1M	$1M	$1M	$1M	$1M	$630.0K	$244.0K	$-83.0K
Pretax Income	·	·	·	·	·	·	·	·	·	·	$-20M	$-17M	$-16M	·	$-18M	$-14M
Income Tax	$0	·	·	·	·	·	·	·	·	$0	$0	$0	$0	$0	$0	$0
Net Income	$170M	$-4M	$-8M	$3M	$-25M	$-13M	$-20M	$-20M	$-18M	$-19M	$-20M	$-17M	$-16M	$-22M	$-18M	$-14M
EPS (Basic)	$0.88	$-0.01	$-0.04	$0.01	$-0.13	$-0.07	$-0.10	$-0.11	$-0.10	$-0.12	$-0.12	$-0.10	$-0.10	$-0.13	$-0.12	$-0.10
EPS (Diluted)	$0.87	$-0.01	$-0.04	$0.01	$-0.13	$-0.07	$-0.10	$-0.11	$-0.10	$-0.12	$-0.12	$-0.10	$-0.10	$-0.13	$-0.12	$-0.10
Shares (Basic)	193,768,641	-382,437,717	191,778,950	191,551,282	190,707,085	-367,055,361	188,997,194	188,041,489	175,625,552	-329,259,017	167,512,708	166,063,284	161,643,404	-297,234,228	150,995,191	148,750,048
Shares (Diluted)	195,214,067	-383,286,168	191,778,950	192,399,733	190,707,085	-367,055,361	188,997,194	188,041,489	175,625,552	-329,259,017	167,512,708	166,063,284	161,643,404	-297,234,228	150,995,191	148,750,048
EBITDA	$169M	·	$-9M	$1M	$-25M	·	$-21M	$-22M	$-19M	·	$-22M	$-18M	$-17M	·	$-18M	$-14M

Neraca 22

Data Triwulanan Neraca untuk ABUS
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$24M	$18M	$22M	$37M	$37M	$36M	$32M	$63M	$43M	$26M	$18M	$27M	$41M	$31M	$24M	$47M
Short-term Investments	·	$73M	·	·	·	$86M	·	·	·	$100M	·	·	·	$116M	·	·
Receivables	$1M	$1M	$905.0K	$1M	$1M	$2M	$2M	$2M	$2M	$2M	$2M	$3M	$3M	$1M	$2M	$2M
Prepaid Expense	$2M	$2M	$3M	$4M	$3M	$2M	$3M	$4M	$4M	$4M	$5M	$4M	$3M	$3M	$5M	$6M
Current Assets	$277M	$94M	$97M	$103M	$117M	$127M	$133M	$148M	$136M	$132M	$142M	$159M	$153M	$151M	$141M	$158M
PP&E (Net)	$22.0K	$32.0K	$137.0K	$148.0K	$168.0K	$3M	$4M	$4M	$4M	$5M	$5M	$5M	$5M	$5M	$5M	$5M
PP&E (Gross)	·	$245.0K	·	·	·	$16M	·	·	·	$17M	·	·	·	$16M	·	·
Accum. Depreciation	$224.0K	$213.0K	$13M	$13M	$13M	$13M	$13M	$13M	$12M	$12M	$12M	$11M	$11M	$11M	$10M	$10M
Other Non-current Assets	$131.0K	$130.0K	$131.0K	$0	$34.0K	$34.0K	·	·	·	$0	$3.0K	$11.0K	$62.0K	$103.0K	$167.0K	$180.0K
Total Assets	$277M	$95M	$98M	$103M	$117M	$132M	$140M	$160M	$150M	$144M	$159M	$177M	$191M	$195M	$204M	$216M
Accounts Payable	$4M	$5M	$5M	$5M	$12M	$8M	$8M	$11M	$8M	$10M	$10M	$9M	$10M	$16M	$12M	$12M
Current Liabilities	$5M	$6M	$5M	$5M	$19M	$16M	$19M	$23M	$20M	$22M	$22M	$25M	$25M	$33M	$28M	$30M
Capital Leases	$0	$199.0K	$391.0K	$575.0K	$626.0K	$806.0K	$978.0K	$1M	$1M	$1M	$1M	$2M	$2M	$2M	$2M	$2M
Total Liabilities	$17M	$18M	$20M	$20M	$38M	$34M	$34M	$38M	$36M	$38M	$39M	$42M	$47M	$59M	$58M	$63M
Long-term Debt	$0	$0	$0	$0	$0	·	$0	$0	$0	·	$0	$0	$0	·	$0	$0
Common Stock	$1.44B	$1.42B	$1.42B	$1.42B	$1.42B	$1.41B	$1.41B	$1.40B	$1.38B	$1.35B	$1.35B	$1.34B	$1.34B	$1.32B	$1.31B	$1.30B
Paid-in Capital	$74M	$83M	$83M	$83M	$82M	$82M	$81M	$82M	$80M	$81M	$80M	$77M	$74M	$72M	$71M	$69M
Retained Earnings	$-1.21B	$-1.38B	$-1.38B	$-1.37B	$-1.37B	$-1.35B	$-1.33B	$-1.31B	$-1.29B	$-1.28B	$-1.26B	$-1.24B	$-1.22B	$-1.20B	$-1.18B	$-1.16B
AOCI	$-48M	$-48M	$-48M	$-48M	$-48M	$-48M	$-48M	$-48M	$-48M	$-48M	$-49M	$-49M	$-50M	$-50M	$-51M	$-50M
Stockholders' Equity	$260M	$77M	$77M	$83M	$79M	$97M	$107M	$122M	$115M	$106M	$119M	$135M	$144M	$137M	$146M	$153M
Liabilities + Equity	$277M	$95M	$98M	$103M	$117M	$132M	$140M	$160M	$150M	$144M	$159M	$177M	$191M	$195M	$204M	$216M
Shares Outstanding	196,947,757	192,531,225	191,953,665	191,641,511	191,481,474	189,963,492	189,438,135	188,739,044	180,192,227	169,867,414	167,695,247	166,922,739	165,132,193	157,455,363	152,711,702	148,794,262

Arus Kas 11

Data Triwulanan Arus Kas untuk ABUS
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
D&A	$11.0K	·	$11.0K	$11.0K	$330.0K	·	$336.0K	$356.0K	$355.0K	·	$369.0K	$342.0K	$334.0K	·	$343.0K	$383.0K
Stock-based Comp	$1M	$1M	$1M	$864.0K	$4M	$2M	$2M	$3M	$2M	$2M	$2M	$3M	$2M	$2M	$2M	$2M
Restructuring	$0	$-12M	$98.0K	$12M	$12M	$95.0K	$4M	$0	$0	$0	$0	·	·	·	·	·
Other Non-cash	$-179M	·	·	·	$7M	·	·	·	$-4M	·	·	·	$-13M	·	·	·
Operating Cash Flow	$-8M	$-5M	$-6M	$-16M	$-13M	$-10M	$-21M	$-15M	$-19M	$-17M	$-22M	$-20M	$-27M	$-17M	$-19M	$-20M
CapEx	·	$0	$0	$0	$0	$86.0K	$0	$1.0K	$95.0K	$0	$32.0K	$859.0K	$117.0K	$134.0K	$91.0K	$212.0K
Investing Cash Flow	$2M	$-1M	$-10M	$16M	$11M	$13M	$-12M	$10M	$12M	$22M	$10M	$1M	$17M	$13M	$-14M	$-14M
Financing Cash Flow	$12M	$2M	$844.0K	$453.0K	$3M	$1M	$2M	$24M	$24M	$4M	$2M	$5M	$20M	$11M	$9M	$113.0K
Net Change in Cash	$6M	$-4M	$-15M	$336.0K	$746.0K	$4M	$-31M	$20M	$17M	$9M	$-10M	$-13M	$10M	$7M	$-23M	$-34M
Free Cash Flow	·	·	·	·	$-13M	·	·	·	$-19M	·	·	·	$-27M	·	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	·	·	·	$-28M	·	·	·

Profitabilitas 7

Data Triwulanan Profitabilitas untuk ABUS
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Operating Margin	94.3%	·	-1636.9%	13.9%	-1456.9%	·	-1601.2%	-1250.5%	-1263.9%	·	-462.8%	-395.3%	-260.4%	·	-299.2%	-99.1%
Net Margin	94.7%	·	-1463.5%	23.5%	-1390.4%	·	-1472.5%	-1146.9%	-1166.8%	·	-431.6%	-367.5%	-244.3%	·	-295.1%	-99.7%
Pretax Margin	·	·	·	·	·	·	·	·	·	·	-431.6%	-367.5%	-244.3%	·	-295.1%	-99.7%
EBITDA Margin	94.3%	·	-1636.9%	13.9%	-1438.2%	·	-1601.2%	-1250.5%	-1240.7%	·	-462.8%	-395.3%	-255.4%	·	-299.2%	-99.1%
ROA	86.1%	·	-6.5%	1.9%	-18.4%	·	-13.2%	-11.8%	-10.5%	·	-11.1%	-8.7%	-7.6%	·	-9.5%	-8.1%
ROE	100.0%	·	-8.4%	2.5%	-25.3%	·	-17.4%	-15.4%	-13.8%	·	-15.2%	-11.9%	-10.5%	·	-12.8%	-11.2%
ROIC	·	·	·	·	·	·	·	·	·	·	-18.1%	-13.7%	-12.1%	·	-12.2%	-9.2%

Likuiditas & Solvabilitas 3

Data Triwulanan Likuiditas & Solvabilitas untuk ABUS
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	54.3	·	18.8	20.5	6.0	·	7.0	6.6	6.7	·	6.3	6.5	6.1	·	5.1	5.3
Quick Ratio	4.9	·	4.5	7.7	2.0	·	1.8	2.9	2.2	·	0.9	1.2	1.7	·	0.9	1.7
Interest Coverage	·	·	·	·	·	·	·	-634.8	-440.1	·	-468.7	-107.5	-87.9	·	-41.5	-29.3

Efisiensi 2

Data Triwulanan Efisiensi untuk ABUS
Metrik	Tren	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover		0.9	·	0.0	0.1	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.1
Receivables Turnover		143.6	·	0.4	7.7	1.1	·	0.7	0.8	0.6	·	2.3	2.0	3.4	·	3.4	8.7

Per Saham 5

Data Triwulanan Per Saham untuk ABUS
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$1.32	·	$0.40	$0.43	$0.41	·	$0.56	$0.65	$0.64	·	$0.71	$0.81	$0.87	·	$0.95	$1.03
Revenue / Share	$0.92	·	$0.00	$0.06	$0.01	·	$0.01	$0.01	$0.01	·	$0.03	$0.03	$0.04	·	$0.04	$0.10
Cash Flow / Share	$-0.04	·	·	·	$-0.07	·	·	·	$-0.11	·	·	·	$-0.17	·	·	·
Cash / Share	$0.12	·	$0.12	$0.20	$0.19	·	$0.17	$0.33	$0.24	·	$0.10	$0.16	$0.25	·	$0.16	$0.32
EPS (TTM)	$0.71	·	$-0.26	$-0.33	$-0.44	·	$-0.43	$-0.43	$-0.42	·	$-0.44	$-0.42	$-0.43	·	$-0.57	$-0.68

Valuasi (TTM) 10

Data Triwulanan Valuasi (TTM) untuk ABUS
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$192M	·	$14M	$16M	$6M	·	$9M	$13M	$18M	·	$22M	$32M	$39M	·	$36M	$32M
Net Income TTM	$140M	·	$-49M	$-62M	$-82M	·	$-77M	$-75M	$-71M	·	$-71M	$-65M	$-64M	·	$-67M	$-69M
Market Cap	$886M	·	$871M	$592M	$668M	·	$729M	$583M	$465M	·	$340M	$384M	$500M	·	$292M	$403M
P/E	6.3	·	-17.5	-9.4	-7.9	·	-9.0	-7.2	-6.1	·	-4.6	-5.5	-7.0	·	-3.4	-4.0
P/S	4.6	·	60.6	38.0	105.1	·	78.8	46.4	26.5	·	15.5	12.2	12.7	·	8.1	12.4
P/B	3.4	·	11.3	7.1	8.4	·	6.8	4.8	4.1	·	2.9	2.9	3.5	·	2.0	2.6
P / Tangible Book	3.4	·	11.3	7.1	8.4	·	6.8	4.8	4.1	·	2.9	2.9	3.5	·	2.0	2.6
P / Cash Flow	-109.3	·	·	·	-49.9	·	·	·	-24.1	·	·	·	-18.3	·	·	·
P / FCF	·	·	·	·	-49.9	·	·	·	-24.0	·	·	·	-18.2	·	·	·
Earnings Yield	15.8%	·	-5.7%	-10.7%	-12.6%	·	-11.2%	-13.9%	-16.3%	·	-21.7%	-18.3%	-14.2%	·	-29.8%	-25.1%

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

Laporan Laba Rugi

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Pendapatan	$14M	$6M	$18M	$39M	$11M
Margin Operasi %	-271.0%	-1236.7%	-430.5%	-167.8%	-669.1%
Laba Bersih	$-34M	$-70M	$-73M	$-69M	$-76M
EPS Dilusian	$-0.17	$-0.38	$-0.44	$-0.46	$-0.83

Neraca

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rasio Lancar	15.7	8.2	5.9	4.6	14.3
Rasio Cepat	15.5	8.0	5.7	4.5	13.9

Arus Kas

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Arus Kas Bebas	$-40M	$-65M	$-87M	$-36M	$-68M

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

Arbutus Biopharma (ABUS) Menangkan Jalur Cepat FDA untuk Imdusiran Yahoo Finance · 3 minggu, 5 hari lalu
Jefferies Melihat Potensi Kenaikan yang Berkurang untuk Arbutus Biopharma Corporation (ABUS) pada Probabilitas Banding yang Lebih Tinggi Yahoo Finance · 1 bulan lalu

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

📊

Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

ABUS Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

ABUS Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

Rata-rata bergerak dan lapisan tumpang tindih

Volume

Osilator

Momentum dan tren

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

ABUS Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

Target Harga 12 Bulan

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

Perbandingan Sejawat Metrik utama vs rekan sektor

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap